Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancer

Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancer - Prediction of response to Neoadjuvant DS therapy in advanced gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011521

Enrollment

Registered

2013-08-19

Start date

2013-08-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinical stageIII gastric cancer

Exclusion criteria

Exclusion criteria: Patients with severe comorbidity

Design outcomes

Primary

Measure	Time frame
Responce rate of neoadjuvant chemotherapy	—

Countries

Japan

Outcome results